Ticker: TPI, Company: TIANYIN PHARMACEUTICAL CO., INC., Type: 8-K, Date: 2015-02-26
Original SEC Filing: Click here

---

Webplus: TPI/20150226/8-K/2_EX-99.1/000.htm SEC Original: f8k022415ex99i_tianyinpharm.htm
CHENGDU, China, Feb. 26, 2015 /PRNewswire/ – Tianyin Pharmaceutical Inc. (NYSE MKT: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API), received notice on February 24, 2015 from the NYSE MKT LLC (the “Exchange”) indicating that the Company is below certain of the Exchange’s continued listing standards,

---

---

Webplus: TPI/20150226/8-K/1/000.htm SEC Original: f8k022415_tianyinpharm.htm

---

Company Information:

Ticker: TPI, Company: TIANYIN PHARMACEUTICAL CO., INC., Type: 8-K, Date: 2015-02-26CIK: 0001362718, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
23RD FLOOR, UNIONSUN YANGKUO PLAZA
CHENGDU, P.R. 610041